Abhilasha Vishwanath, Mitchell J Bartlett, Torsten Falk, Stephen L Cowen
{"title":"Decoupling of motor cortex to movement in Parkinson’s dyskinesia rescued by sub-anaesthetic ketamine","authors":"Abhilasha Vishwanath, Mitchell J Bartlett, Torsten Falk, Stephen L Cowen","doi":"10.1093/brain/awae386","DOIUrl":null,"url":null,"abstract":"Gamma band and single-unit neural activity in primary motor cortex (M1) are involved in the control of movement. This activity is disrupted in Parkinson’s disease (PD) and levodopa-induced dyskinesia (LID), a debilitating consequence of dopamine replacement therapy for PD. Physiological features of LID include pathological narrowband gamma oscillations, finely tuned gamma (FTG), and altered M1 firing activity. Since most studies characterize LID through visual scoring, little is known about the relationships between ongoing dyskinetic movements, gamma, and neuronal activity at fast (sub-second) and slow (seconds) timescales. Here, we investigate how motor cortex activity changes with movement at multiple timescales in animal models of PD and LID. Furthermore, sub-anesthetic ketamine has emerged as a possible therapy for LID. How ketamine may reduce LID is not fully understood. Consequently, we investigate how ketamine affects the relationship between motor cortex activity and movement. To investigate these questions, local-field and single-unit activity from >3000 motor cortex neurons was acquired using a standard model of PD/LID (n = 10 male rats). Data in LID and sham animals was acquired following levodopa (L-DOPA; 12 mg/kg, i.p.) and ketamine (20 mg/kg, i.p.) administration. Movement was assessed using traditional abnormal involuntary movements (AIMs) scores and head-mounted inertial sensors sampled at 200 Hz. While correlations between movement, gamma, and single-unit activity were high in all animals during control conditions, correlations decreased considerably in animal models of LID following L-DOPA administration. This suggests that M1 can become functionally decoupled from ongoing movements in LID. Interestingly, this effect was observed in both the dopamine depleted and non-depleted hemispheres. Ketamine disrupted FTG, decreased LID, and moderately increased single-unit correlations to movement during LID. Ketamine, however, did not enhance the correlation between gamma-band activity and movement. Finally, ketamine exerted a selective effect on neuronal interactions and ensemble activity in LID animals. Specifically, analysis of cell-pair firing-rate correlations showed that ketamine induced a distinct neural ensemble state in LID by reorganizing the pattern of cell-pair interactions. These findings provide insight into the role that motor cortex neurons and gamma-band activity play during healthy movement and LID. Results suggest that primary motor cortex does not directly trigger specific dyskinetic movements during LID but, instead, dysregulated motor cortex activity may permit aberrant movements to spontaneously emerge in downstream circuits. These data further support the anti-dyskinetic properties of ketamine and suggest that ketamine acts to reduce LID by disrupting pathological interactions between motor cortex neurons during dyskinesia.","PeriodicalId":9063,"journal":{"name":"Brain","volume":"13 1","pages":""},"PeriodicalIF":10.6000,"publicationDate":"2024-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Brain","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/brain/awae386","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Gamma band and single-unit neural activity in primary motor cortex (M1) are involved in the control of movement. This activity is disrupted in Parkinson’s disease (PD) and levodopa-induced dyskinesia (LID), a debilitating consequence of dopamine replacement therapy for PD. Physiological features of LID include pathological narrowband gamma oscillations, finely tuned gamma (FTG), and altered M1 firing activity. Since most studies characterize LID through visual scoring, little is known about the relationships between ongoing dyskinetic movements, gamma, and neuronal activity at fast (sub-second) and slow (seconds) timescales. Here, we investigate how motor cortex activity changes with movement at multiple timescales in animal models of PD and LID. Furthermore, sub-anesthetic ketamine has emerged as a possible therapy for LID. How ketamine may reduce LID is not fully understood. Consequently, we investigate how ketamine affects the relationship between motor cortex activity and movement. To investigate these questions, local-field and single-unit activity from >3000 motor cortex neurons was acquired using a standard model of PD/LID (n = 10 male rats). Data in LID and sham animals was acquired following levodopa (L-DOPA; 12 mg/kg, i.p.) and ketamine (20 mg/kg, i.p.) administration. Movement was assessed using traditional abnormal involuntary movements (AIMs) scores and head-mounted inertial sensors sampled at 200 Hz. While correlations between movement, gamma, and single-unit activity were high in all animals during control conditions, correlations decreased considerably in animal models of LID following L-DOPA administration. This suggests that M1 can become functionally decoupled from ongoing movements in LID. Interestingly, this effect was observed in both the dopamine depleted and non-depleted hemispheres. Ketamine disrupted FTG, decreased LID, and moderately increased single-unit correlations to movement during LID. Ketamine, however, did not enhance the correlation between gamma-band activity and movement. Finally, ketamine exerted a selective effect on neuronal interactions and ensemble activity in LID animals. Specifically, analysis of cell-pair firing-rate correlations showed that ketamine induced a distinct neural ensemble state in LID by reorganizing the pattern of cell-pair interactions. These findings provide insight into the role that motor cortex neurons and gamma-band activity play during healthy movement and LID. Results suggest that primary motor cortex does not directly trigger specific dyskinetic movements during LID but, instead, dysregulated motor cortex activity may permit aberrant movements to spontaneously emerge in downstream circuits. These data further support the anti-dyskinetic properties of ketamine and suggest that ketamine acts to reduce LID by disrupting pathological interactions between motor cortex neurons during dyskinesia.
初级运动皮层(M1)中的伽马带和单细胞神经活动参与运动控制。这种活动在帕金森病(PD)和左旋多巴诱发的运动障碍(LID)中受到破坏,左旋多巴诱发的运动障碍是多巴胺替代疗法治疗帕金森病的衰弱后果。LID 的生理特征包括病理性窄带伽马振荡、微调伽马(FTG)和 M1 发射活动改变。由于大多数研究都是通过视觉评分来描述 LID 的特征,因此对正在进行的运动障碍、伽马和神经元活动在快(亚秒级)和慢(秒级)时间尺度上的关系知之甚少。在这里,我们研究了运动障碍和运动迟缓的动物模型中,运动皮层的活动是如何随着运动在多个时间尺度上发生变化的。此外,亚麻醉状态下的氯胺酮已成为一种可能的 LID 治疗方法。氯胺酮是如何减轻运动障碍的,目前尚不完全清楚。因此,我们研究了氯胺酮如何影响运动皮层活动与运动之间的关系。为了研究这些问题,我们使用一个标准的PD/LID模型(n = 10只雄性大鼠)采集了>3000个运动皮层神经元的局部场和单细胞活动。在左旋多巴(L-DOPA;12 毫克/千克,静脉注射)和氯胺酮(20 毫克/千克,静脉注射)给药后采集了 LID 和假动物的数据。运动评估采用传统的异常不自主运动(AIMs)评分和以 200 Hz 频率采样的头戴式惯性传感器。在对照条件下,所有动物的运动、伽马和单细胞活动之间的相关性都很高,但在服用 L-DOPA 后,LID 动物模型的相关性明显降低。这表明,在 LID 中,M1 可以在功能上与正在进行的运动脱钩。有趣的是,在多巴胺耗竭和未耗竭的半球中都观察到了这种效应。氯胺酮扰乱了 FTG,减少了 LID,并适度增加了 LID 期间单细胞与运动的相关性。然而,氯胺酮并没有增强伽马波段活动与运动之间的相关性。最后,氯胺酮对LID动物的神经元相互作用和集合活动产生了选择性影响。具体来说,对细胞对发射率相关性的分析表明,氯胺酮通过重组细胞对的相互作用模式,诱导了LID动物独特的神经集合状态。这些研究结果让我们深入了解了运动皮层神经元和伽马带活动在健康运动和 LID 中的作用。研究结果表明,初级运动皮层在 LID 期间不会直接触发特定的运动障碍,相反,运动皮层活动失调可能会允许异常运动在下游回路中自发出现。这些数据进一步支持了氯胺酮的抗运动障碍特性,并表明氯胺酮在运动障碍期间通过破坏运动皮层神经元之间的病理相互作用而起到减少运动障碍的作用。
期刊介绍:
Brain, a journal focused on clinical neurology and translational neuroscience, has been publishing landmark papers since 1878. The journal aims to expand its scope by including studies that shed light on disease mechanisms and conducting innovative clinical trials for brain disorders. With a wide range of topics covered, the Editorial Board represents the international readership and diverse coverage of the journal. Accepted articles are promptly posted online, typically within a few weeks of acceptance. As of 2022, Brain holds an impressive impact factor of 14.5, according to the Journal Citation Reports.